Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Guanabenz acetate
Drug ID BADD_D01044
Description An alpha-2 selective adrenergic agonist used as an antihypertensive agent. [PubChem]
Indications and Usage For management of High blood pressure
Marketing Status approved; investigational
ATC Code Not Available
DrugBank ID DB00629
KEGG ID D00605
MeSH ID D006143
PubChem ID 5702062
TTD Drug ID D0L4HY
NDC Product Code 86036-002; 71052-123
UNII 443O19GK1A
Synonyms Guanabenz | 2,6-Dichlorobenzylideneaminoguanidine | 2,6 Dichlorobenzylideneaminoguanidine | Guanabenz Acetate | Acetate, Guanabenz | Guanabenz Monoacetate | Monoacetate, Guanabenz | Wytensin | Wyeth-Ayerst of Guanabenz Acetate | Acetate Wyeth-Ayerst, Guanabenz | Guanabenz Acetate Wyeth-Ayerst | Wyeth Ayerst of Guanabenz Acetate | BR-750 | BR 750 | BR750 | WY-8678 | WY 8678 | WY8678
Chemical Information
Molecular Formula C10H12Cl2N4O2
CAS Registry Number 23256-50-0
SMILES CC(=O)O.C1=CC(=C(C(=C1)Cl)C=NN=C(N)N)Cl
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Vision blurred06.02.06.007; 17.17.01.010--
Vomiting07.01.07.003--
Erectile dysfunction19.08.04.001; 21.03.01.007--
The 2th Page    First    Pre   2    Total 2 Pages